Skip to main content
Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.660
-0.040 (-2.35%)
At close: Apr 28, 2026, 4:00 PM EDT
1.700
+0.040 (2.41%)
After-hours: Apr 28, 2026, 6:42 PM EDT

Ocugen Revenue

In the year 2025, Ocugen had annual revenue of $4.41M with 8.83% growth. Ocugen had revenue of $-193.00K in the quarter ending December 31, 2025, a decrease of -125.26%.

Revenue (ttm)
$4.41M
Revenue Growth
+8.83%
P/S Ratio
128.49
Revenue / Employee
$38,043
Employees
116
Market Cap
561.94M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.41M358.00K8.83%
Dec 31, 20244.05M-1.98M-32.82%
Dec 31, 20236.04M3.55M142.60%
Dec 31, 20222.49M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CorMedix 311.71M
Rigel Pharmaceuticals 294.28M
Sutro Biopharma 102.48M
Prothena Corporation 9.68M
Shattuck Labs 1.00M
ProKidney 893.00K
Altimmune 41.00K
Revenue Rankings

OCGN News

More News